Milestone Achieved: Medical Company Approved To Develop This Treatment

Groundbreaking FDA Approval: LP-310, A New Ray of Hope for Oral Lichen Planus Patients

Disclaimer: This post includes references to Lipella Pharmaceuticals Inc., the company behind LP-310. The author has no financial interest or received any material support from Lipella Pharmaceuticals Inc. or any other associated entity. Any views expressed are the author's alone and do not represent the official stance of the aforementioned entities.

Th…